Newsletter September 2018 No.187
Top News
On "The Framework Policy 2018"
On June 15, 2018, the Cabinet approved the "Basic Policies for Economic and Fiscal Management and Reform 2018 - Achieving a Sustainable Growth Path by Overcoming the Declining Birthrate and Aging Population" (the so-called "Keto-buta Policy 2018"). Along with the "Keto Policy 2018," the Cabinet also approved the "Future Investment Strategy 2018," the "Regulatory Reform Implementation Plan," and the "Basic Plan for Urban, Human, and Workplace Creation 2018" all together this time. This paper outlines the parts of the "Kotta Policy 2018" that are expected to have a relatively large impact on the pharmaceutical industry.
Topics
- The 2nd Compliance Practitioners Meeting" was held
- 2018 APEC Business Ethics Forum (Tokyo Meeting)" Held Putting Patients First: Patient Groups, Medical Associations, Pharmaceutical and Medical Device Organizations, and the Ministry of Health, Labor and Welfare Sign on for Ethical Collaboration among Stakeholders
- The 6th ICH Association Meeting "ICH Kobe Conference" is held
- The regular meeting with the French Pharmaceutical Association (LEEM) was held.
- The 3rd Japan-Korea Symposium on Regulation of Medical Products" was held.
- First GRM (Good Registration Management) CoE workshop held in Thailand and Malaysia
- Safety and Health Technical Workshop
- Held "Recent Development on Evaluation Metrics for Survival Time Analysis - Understanding the Restricted Mean Survival Time (RMST)
Policy Research Institute page
From JPMA
Challenges to Drug Discovery Innovation